14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $50.35 $57.15 Thursday, 2nd May 2024 INCY stock ended at $53.09. This is 0.283% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 2.26% from a day low at $52.28 to a day high of $53.46.
90 days $50.35 $61.87
52 weeks $50.27 $67.72

Historical Incyte Corporation prices

Date Open High Low Close Volume
Feb 21, 2024 $59.08 $60.46 $59.05 $60.33 1 902 793
Feb 20, 2024 $57.79 $59.50 $57.65 $58.82 1 860 724
Feb 16, 2024 $58.88 $59.11 $57.92 $57.96 1 091 914
Feb 15, 2024 $58.09 $59.87 $57.89 $58.97 1 389 685
Feb 14, 2024 $58.59 $60.20 $57.51 $57.89 2 175 772
Feb 13, 2024 $60.04 $60.62 $57.83 $59.34 3 444 842
Feb 12, 2024 $57.79 $58.43 $57.38 $57.84 2 176 334
Feb 09, 2024 $57.37 $57.96 $57.09 $57.66 1 723 906
Feb 08, 2024 $57.35 $57.66 $56.10 $57.36 1 647 153
Feb 07, 2024 $59.24 $59.57 $57.34 $57.34 1 239 980
Feb 06, 2024 $58.50 $59.94 $57.69 $59.63 1 961 105
Feb 05, 2024 $58.00 $58.47 $57.63 $58.06 1 170 763
Feb 02, 2024 $58.63 $59.27 $58.05 $58.35 1 086 961
Feb 01, 2024 $58.52 $59.27 $58.03 $59.16 1 165 416
Jan 31, 2024 $59.30 $59.48 $58.52 $58.77 1 542 974
Jan 30, 2024 $60.50 $60.50 $59.15 $59.28 1 469 646
Jan 29, 2024 $60.36 $60.84 $59.77 $60.47 1 093 084
Jan 26, 2024 $61.32 $61.70 $60.30 $60.64 1 030 054
Jan 25, 2024 $60.73 $61.31 $59.58 $60.92 1 083 582
Jan 24, 2024 $62.05 $62.14 $60.78 $60.84 1 274 645
Jan 23, 2024 $61.73 $62.19 $60.93 $61.87 1 071 382
Jan 22, 2024 $61.81 $61.89 $60.61 $61.50 1 075 603
Jan 19, 2024 $61.28 $61.67 $60.45 $61.49 1 075 128
Jan 18, 2024 $61.30 $61.54 $60.27 $61.18 1 138 779
Jan 17, 2024 $61.18 $61.84 $60.45 $61.48 1 168 281
Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT